2.09
Sera Prognostics Inc stock is traded at $2.09, with a volume of 59,989.
It is up +4.50% in the last 24 hours and down -8.73% over the past month.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
See More
Previous Close:
$2.00
Open:
$1.98
24h Volume:
59,989
Relative Volume:
1.21
Market Cap:
$81.84M
Revenue:
$57,000
Net Income/Loss:
$-32.14M
P/E Ratio:
-3.2323
EPS:
-0.6466
Net Cash Flow:
$-27.58M
1W Performance:
+15.47%
1M Performance:
-8.73%
6M Performance:
-29.39%
1Y Performance:
-16.06%
Sera Prognostics Inc Stock (SERA) Company Profile
Name
Sera Prognostics Inc
Sector
Industry
Phone
(801) 990-0520
Address
2749 E. PARLEYS WAY, SALT LAKE CITY
Compare SERA vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SERA
Sera Prognostics Inc
|
2.09 | 71.27M | 57,000 | -32.14M | -27.58M | -0.6466 |
|
ABT
Abbott Laboratories
|
95.63 | 158.05B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
324.73 | 120.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
83.06 | 100.14B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.60 | 63.44B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
95.18 | 52.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Initiated | Jefferies | Buy |
| Mar-30-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | Oppenheimer | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
Sera Prognostics Inc Stock (SERA) Latest News
Director Mark Christopher Capone files Form 3 for Sera Prognostics (SERA) - Stock Titan
Sera Prognostics, Inc. Class A Actuals & Estimates (NASDAQ:SERA) - TradingView
Sera Prognostics adds former Myriad Genetics CEO to board By Investing.com - Investing.com South Africa
Sera Prognostics, Inc. Announces Appointment of Mark Capone to Board of Directors, Effective July 1, 2026 - marketscreener.com
Sera Prognostics Adds Veteran Executive to Board - TipRanks
Mark Capone appointed to Sera Prognostics board, joins Compensation Committee - TradingView
Veteran diagnostics leader Mark Capone joins Sera Prognostics (NASDAQ: SERA) board - Stock Titan
Press Release: SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS - Moomoo
Sera Prognostics (SERA) Edges Higher as Stock Tests Key Resistance LevelStop Run - dars.gov.et
Sera Prognostics, Inc.(NasdaqGM:SERA) added to Russell Microcap Value Benchmark Index - marketscreener.com
Sera Prognostics, Inc.(NasdaqGM: SERA) added to Russell 3000E Value Benchmark - marketscreener.com
Sera Prognostics, Inc. Class A Actuals & Estimates (BOATS:SERA) - TradingView
SERA Forecast — Price Target — Prediction for 2027 - TradingView
Sera Prognostics (SERA) loses 27% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Price to earnings forward of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView
Price to sales forward of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView
SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH - PR Newswire
Price to book forward of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView
Enterprise value to EBIT forward of Sera Prognostics, Inc. – BOATS:SERA - TradingView
Illinois expands Medicaid coverage for preterm birth tests By Investing.com - Investing.com South Africa
Illinois expands Medicaid coverage for preterm birth tests - Investing.com UK
SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY - PR Newswire
All you need to know about Sera Prognostics (SERA) rating upgrade to buy - MSN
All You Need to Know About Sera Prognostics (SERA) Rating Upgrade to Buy - Yahoo Finance
SERA News | SERA PROGNOSTICS INC-A (NASDAQ:SERA) - ChartMill
Sera Prognostics Inc (SERA) Institutional Confidence - TradingKey
Sera Prognostics Inc (SERA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sera Prognostics Inc (SERA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sera Prognostics Inc (SERA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sera Prognostics Inc (SERA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sera Prognostics Inc (SERA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sera Prognostics Inc (SERA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sera Prognostics Inc (SERA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sera Prognostics Inc (SERA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SERA (NASDAQ: SERA) CCO sells 4,739 shares to cover RSU tax withholding - Stock Titan
Sera Prognostics (NASDAQ: SERA) CFO sells shares to cover RSU tax obligations - Stock Titan
SERA PROGNOSTICS (NASDAQ: SERA) CEO tax-related share sale disclosed - Stock Titan
SERA (NASDAQ: SERA) CMO executes 362-share tax sell-to-cover trade - Stock Titan
SERA (SERA) General Counsel sells 2,179 shares to cover RSU taxes - Stock Titan
SERA (NASDAQ) Form 144: Class A Common sales tied to RSU vesting on 06/11/2026 - Stock Titan
Sera Prognostics Q1 2026 Earnings: In-Line EPS as Company Advances Proteomic PlatformEstimate Revision Count - newsline.com
Sera Prognostics CEO Lindgardt sells $43,170 in company stock By Investing.com - Investing.com Canada
Sera Prognostics CEO Lindgardt sells $43,170 in company stock - Investing.com UK
SERA (SERA) CEO Lindgardt sells 20,755 shares to cover RSU tax withholding - Stock Titan
Sera Prognostics (SERA) CFO sells shares to cover RSU tax obligations - Stock Titan
Proposed Class A Common resale — SERA (NASDAQ: SERA) 06/09/2026 - Stock Titan
Insider Sell: Sandra Lawrence Sells Shares of Sera Prognostics I - GuruFocus
Director at Sera Prognostics (SERA) sells 1,560 planned shares - Stock Titan
Sera Prognostics (SERA) Q4 2025 Earnings Call Transcript - MLQ.ai
[144] SERA PROGNOSTICS, INC. SEC Filing - Stock Titan
Sera Prognostics, Inc. 8-K SEC Filing June 2026 – Submission of Matters to a Vote of Security Holders - Minichart
Sera Prognostics Inc Stock (SERA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sera Prognostics Inc Stock (SERA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Aerts Austin | Chief Financial Officer |
Jun 11 '26 |
Sale |
2.01 |
2,037 |
4,094 |
301,190 |
| Lindgardt Zhenya | Chief Executive Officer |
Jun 11 '26 |
Sale |
2.01 |
6,990 |
14,050 |
865,009 |
| Inglis Tiffany Eul Davis | Chief Medical Officer |
Jun 11 '26 |
Sale |
2.01 |
362 |
728 |
92,075 |
| Jackson Benjamin | General Counsel |
Jun 11 '26 |
Sale |
2.01 |
2,179 |
4,380 |
161,756 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):